{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-069783","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.094530+00:00","generated_at":"2026-05-21T16:05:54.927973+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Stoke Therapeutics Q1 2025 net income $112.9M; advances zorevunersen Phase 3 with Biogen","bullets":["Net income $112.9M ($1.90 diluted EPS) in Q1 2025 vs net loss $26.4M ($0.57 per share) in Q1 2024.","Revenue $158.5M, including $152.4M from Biogen license fee and $6.1M from Acadia partnership.","Cash position $380.3M as of Mar 31, 2025; projected to fund operations beyond mid-2028.","Phase 3 EMPEROR study of zorevunersen for Dravet syndrome cleared with FDA, EMA, PMDA; enrollment in Q2 2025.","Biogen collaboration: $165M upfront, potential $385M milestones, tiered royalties; Stoke retains North America rights."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-069783","json":"https://secwatch.observer/filing/0000950170-25-069783.json","markdown":"https://secwatch.observer/filing/0000950170-25-069783.md","text":"https://secwatch.observer/filing/0000950170-25-069783.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000095017025069783/0000950170-25-069783-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000095017025069783/stok-20250513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T16:05:54.927973+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}